Successful management of depression with reboxetine in a patient who developed parkinsonism related to paroxetine use

Abstract

Get full access to this article

View all access options for this article.

References

American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders, fourth ed, Text Revision . Washington, DC: American Psychiatric Association.

Caley, F. , Friedman, JH ( 1992) Does fluoxetine exacerbate Parkinson’s disease? J Clin Psychiatry 53: 278-282.

Detweiler, MB , Harpold, GJ ( 2002) Bupropion induced acute dystonia. Ann Pharmacother 36: 251-254.

Goldberg, RJ ( 1998) Selective serotonin reuptake inhibitors: infrequent medical adverse effects. Arch Fam Med 7: 78-84.

Hajós, M. , Fleishaker, JC , Filipiak-Reisner, JK , Brown, MT , Wong, EH ( 2004) The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile. CNS Drug Rev 10: 23-44.

Hamilton, M. ( 1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.

Hedenmalm, K. , Güzey, C. , Dahl, ML , Yue, QY , Spigset, O. ( 2006) Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. J Clin Psychopharmacol 26: 192-197.

Jimenez, FJ , Molina, AJ ( 2000) Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors. CNS Drugs 14: 367-379.

Lu, R. , Hurley, AD , Gourley, M. ( 2002) Dystonia induced by mirtazapine. J Clin Psychiatry 63: 452-453.

10.

Ozalp, E. , Soygur, H. , Cankurtaran, ES , Turhan, L. , Cekic, T. , Akarsu, ES , et al. (2006) Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report. Prog Neuropsychopharmacol Biol Psychiatry 30: 1337-1339.

11.

Pintor, L. , Baillès, E. , Valldeoriola, F. , Tolosa, E. , Martí, MJ , de Pablo, J. ( 2006) Response to 4-month treatment with reboxetine in Parkinson’s disease patients with a major depressive episode. Gen Hosp Psychiatry 28: 59-64.

12.

Schillevoort, I. , van Puijenbroek, EP , de Boer, A. ( 2002) Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol 17: 75-79.

13.

Simpson, G. , Angus, J. ( 1970) Drug induced extrapyramidal disorders. Acta Psychiatr Scand 45: 11-19.

14.

Tanum, L. ( 2000) Reboxetine: tolerability and safety profile in patients with major depression. Acta Psychiatr Scand 402: 37-40.

15.

Vaswani, M. , Linda, FK , Ramesh, S. ( 2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27: 85-102.